Intervention

Blood draw for the laboratory assessment

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting4

Common conditions13

Lead sponsors shown6

Clinical trials

6 shown

Radiation Therapy and Thymus Function in Young Women With Breast CancerNCT07725172 · 2026-09-01

Validation of α-synuclein Modifications in Parkinson's dIsoRder EvolutionNCT06941012 · 2025-05-12

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South WalesNCT06914778 · 2025-03-31

Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.NCT06865274 · 2025-02-20

Comparison Immune Response in Paravertebral and Erector Spinal Plane Block in Breast Cancer PatientsNCT07648810 · 2026-06-15

NOT_YET_RECRUITING

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)NCT07475923 · 2026-04-09

Common conditions

Breast Cancer2 Breast Cancer - Female1 ctDNA1 Diabetic Macular Edema (DME)1 Diabetic Retinopathy (DR)1 Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus1 MOGAD1 Molecular Surveillance1 MRD1 Multiple Sclerosis1 Neuromyelitis Optica Spectrum Disorders1 Observational Study1 Parkinson Disease (PD)1

Leading sponsors

Casa di Cura IGEA1 Clinical Hospital Center Rijeka1 Duke University1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 Hywel Dda Health Board1 M.D. Anderson Cancer Center1

Trial status mix

RECRUITING4

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.